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ABSTRACT  
Objective: The lack of information concerning the pharmacological activity of amino acetylenic amide derivatives in which the cyclic amine is 
aziridine or azetidine promoted our interest to synthesize N-[4-(1-azeridinyl)-2-butynyl] pyrrolide-1,3-dione 4, N-[4-(1-azetidinyl)-2-butynyl] 
pyrrolidine-1,3-dione 5 and N-[4-(1-pyrrolidnyl)-2-butynyl]pyrrolide-1,3-dione 6.  
Methods: Melting points, IR, 1H-NMR 13CNMRspectra were measured.  
Results: Dimerization of 2-(prop-2-yn-1-yl) pyrrolidine-1,3-dione was generated rather than Mannich product, while using pyrrolidine as base in 
Mannich reaction generated the expected Mannich product. Rationalization for the mechanism of dimerization and Mannich adduct are discussed.  
Conclusion: Mannich reaction may afford the dimerization product of the acetylenic compounds rather than Mannich adduct. 
Keywords: Acetylenic dimerization, Aminoactylenic derivative, Azetidine derivative, Aziridine derivative, Mannich reaction.  
 
INTRODUCTION  
Tremorine 1 and Oxotremorine 2 was very active muscarinic agent 3 
when tested in vivo, or in isolated organs and comparable to 
acetylcholine in potency [1]. They are relatively specific in producing 
central, as opposed to peripheral cholinergic effects [2]. 
Observations of Parkinson like effect exerted by tremorine and more 
intense by oxotremorine have initiated intensive research on 
antiparkinsonian agents, in particular from their central cholinergic 
role in reducing tremor [3]. Several series of acetylenic compounds 
which were structurally related to oxotremorine with specific 
structural changes to afford the antagonistic activity have been 
synthesized. These include amides, esters, cyclicimides [3-10].  
In most of the previously synthesized compounds [3-10], the cyclic 
amines were pyrrolidine, piperidine, substituted piperidine and ring 
enlargement of cyclic amines. The lack of information concerning the 
pharmacological activity of amino acetylenic amide derivatives, in 
which the cyclic amine is aziridine or azetidine promoted our 
interest to synthesize N-[4-(1-azeridinyl)-2-butynyl] pyrrolide-1,3-
dione 4, N-[4-(1-azetidinyl)-2-butynyl] pyrrolidine-1,3-dione 5 and 
N-[4-(1-pyrrolidnyl)-2-butynyl] pyrrolide-1,3-dione 6. The Mannich 
reaction of pyrrolidine as base generated Mannich adduct 6, 
however the use of aziridine or azetidine as a base resulted in 
dimerization of acetylenic pyrrolidine-1,3-dione into 1-[6-(1,3-
dioxopyrrolidine-1-yl) hexa-2,4-diyn-1-yl] pyrrolidine-1,3-dione, 
and investigating their pharmacological activity as oxotremorine 
agonist or antagonist, in addition to establish whether ring strain of 
the cyclic amines may block the formation of mannich adduct. 
Rationalization for the mechanisms of dimerization and Mannich 






Fig. 1: Tremonine 1 
 





Fig. 3: Muscarine 3 
 
MATERIALS AND METHODS 
Experimental  
Chemical methods 
Melting points were determined by using a calibrated Thomas-
Hoover melting apparatus. IR spectra were recorded using Perkin-
Elmer 257 spectrophotometer, 1H-NMR spectra were acquired with 
the aid of Varian 300 MHz spectrometer and DMSO-d6 as solvent and 
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TMS as standard (Jordan University), 13CNMR spectra were 
measured using Bruker DRX 300 MHz spectrometer and DNCO-d6 as 
solvent and TMS as standard (Jordan University). 
 
Fig. 4: N-[4-(aziridin-1-y1) but-2-yn-1-y1] pyrrolidin-2,5-dione 
 
 
Fig. 5: N-[4-(aziridin-1-y1) but-2-yn-1-y1] pyrrolidin-1,3-dione 
 
 
Fig. 6: N-[4-(pyrrolidin -1-y1) but-2-yn-1-y1] pyrrolidin-1,3-
dione 
 
Microanalyses were performed at oil exploring company, Baghdad, 
Iraq. The results obtained had a maximum deviation of±0.4% of the 
theoretical value.  
2-(prop-2-yn-1-yl) pyrrolidine-1,3-dion 7 
The compound was prepared in 75.4% yield according to the 
method described in the literatures [5-6].  
1-[6-(1,3-dioxopyrrolidin-1-yl)hexa-2,4-diyn-1-yl]pyrrolidine-
1,3-dione. 10  
A mixture of 2-[prop-2-yn-1-yl]pyrrolidine-1,3dione (1.37 g, 0.01 
mol), paraformaldehyde (1 g, 0.01 mol), azetidine (0.57 g, 0.01 mol) 
and cuprous chloride (catalytic amount) in peroxide-free dioxane 
(20 ml) was stirred and heated at various temperatures (40-70 oC) 
for 1-2 h. After cooling, water (20 ml) was added and the reactant 
mixture was made alkaline to pH 9 with 2 M Na2CO3 and extracted 
with four (50 ml) of chloroform. The combined chloroform extracts, 
dried (anhydrous MgSO4). The solvent was removed under reduced 
pressure. The residue was subjected to purification by column 
chromatography on Al2O3. The combined suitable chloroform 
fractions were dried (MgSO4) and the solvent was removed under 
reduced pressure, the residue crystallized on standing affording 0.5 
g of white crystalline 1-[6-(1,3-dioxopyrrolidin-1-yl) hexa-2,4-diyn-
1-yl]pyrrolidine-1,3-dione, M. P. 193-194 oC. The IR spectra showed 
the following characteristic absorption bands (KBr, cm-1), 3010, 
2980 (CH2), 2400 (weak, C≡C-C≡C), 1760, 1720 (C=O, imide). 1H-
NMR spectrum showed the following characteristic chemical shifts 
(CDCL3, δ) 4.20 (singlet, 4H, CH2-C≡C-C≡C-CH2), 2.45 (singlet, 8H, (-
CH2-CH2-)2 of imide. 13CNMR (CDCL3,δ) 178 (C=O), 76 (-C≡), 71 
(≡C),36 (C-C=O), 30(C=C≡). Anal., (C14H12N2O4), Calcd., C, 61.8; H, 
4.4; N, 10.3. Found C, 61.8; H, 4.5; N, 10.2.  
N-[4-(1-pyrrolidin-1-yl) but-2-yn-1-yl] pyrrolidine-1,3-dione. 6  
A mixture of 2-(prop-2-yn-yl) proolidine-1,3-dione (0.005 mol), 
paraformaldehyde (0.0055 mol), pyrrolidine (0.007 mol) and 
cuprous chloride (catalytic amount) in peroxide-free dioxane (20 
ml) was heated with continuous stirring at 40-70 oC for 2 h. After 
cooling, ice (50 g) was added and the crude product was 
crystalized from ethanol-ether afforded 72% yield of the N-[4-(1-
pyrrolidine)-2-butynyl] pyrrolidine-1,3-dione. M. P. 91-92 oC. The 
IR spectrum showed the following characteristic absorption bands 
(KBr, cm-1), 2980, 2800 (CH2), 2200 (weak, C≡C), 1770, 1715 
(C=O, imide). 1H-NMR spectrum showed the following 
characteristic chemical shifts (CDCL3, δ) 4.25 (triplet, 2H, CH2-C= C, 
adjacent to imide nitrogen, J=2.2 Hz) 3.30 (triplet, 2H, C≡C-CH2, 
adjacent to the pyrrolidine nitrogen, J=2.2 Hz), 2.71 (singlet, 4H, 
CO-CH2-, CH2-CO, imide), 2.58 (multiplet 4H, N-(CH2)2, α-to N-
pyrrolidine) 1.78 (multiplet, 4H,-CH2-CH2-of pyrrolidine). 13CNMR 
(CDCL3, δ) 174 (C=O), 80 (C≡C), 51 (N-C-C≡), 43 (≡C-C), 32,28 (C-
C, pyrrolidine-1,3-dione), 25 (N-C, pyrrolidine), 22 (C-C, 
pyrrolidine). Anal., (C12H16N2O2), Calcd., C, 65.45; H, 7.27; N, 12.72. 
Found C, 65.41; H, 7.23; N, 12.69.  
RESULTS AND DISCUSSION 
Pyrrolidine-1,3-dione served as starting material, and was converted 
to the corresponding sodium salt through reaction with sodium 
ethoxide. Alkylation of the imide salt with propargyl bromide afforded 
the desired N-propynyl pyrrolidine-1,3-dione 7. The Mannich reaction 
of N-propynyl pyrrolidine-1,3-dione, formaldehyde and aziridine or 
azetidine, as secondary amine, in peroxide-free dioxane in the 
presence of catalytic amount of cuprous chloride and temperature 
conditions between 60-70 oC [11, 12], resulted in a single non basic 
compound, the MP, IR, 1H-NMR, 13CNMR and elemental analyses were 
consistent with the dimerization of propynyl pyrrolidine-1,3-dione 
affording coupling product [13-17] namely 1[6-(1,3-dioxopyrrolidin-
1-yl)hexa-2,4-diyn-1-yl]pyrrolidine-1,3-dione 10 rather than the 
Mannich adduct 4 or 5.  
It is very well know that 1-alkynes may be coupled by heating with 
cupric or cupreous salts in pyridine, ammonia, ammonium chloride 
or similar basis to produce symmetrical diynes. The mechanism of 
dimerization probably begins with ionized salt formation of 8 and 
HCL liberation. The carbanion undergoes oxidation to yield the free 
radical propynyl pyrrolidine-1,3-dione 9. Dimerization of 9 
generates the dimerization product 10 as an outline in scheme 1.  
For the Mannich reaction to precede reactive immnoium cations 
intermediate 9 should be formed, from the condensation of 
formaldehyde and aziridine or azetidine [17] prior to the attack of 
the carbanion 6 on the intermediate 9 to generate Mannich adducts 
as described in scheme 2.  
The reasonable rationalization for dimerization rather than Mannich 
adduct may be due to the angle strain imposed by the three or four 
member ring amine to form 11. Thus, providing time for oxidation of 
carbanion 8 to the free radical 9, followed by dimerization to afford 
coupling product 10.  
The aziridine and azetidine in this case, act as a base in a similar 
manner to pyridine or ammonia. To verify ring strain effects we have 
synthesized Mannich reaction in 2-(prop-2-yn-1-yl) pyrrolidine-1,3-
dione with pyrrolidine as unstrained secondary amine. The reaction 
afforded the desired Mannich product N-[4-(1-pyrrolidino)-2-
butynyl] pyrrolidine-1,3-dione 6 only.  
The IR, 1H-NMR, 13 CNMR and elemental analyses was consistent 
with the assigned structures as described in the experimental part. 
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The following steps take place during Mannich reaction.     
 
Scheme 2: Mannich product 
 
CONCLUSION  
We may state that the Mannich reaction may afford the dimerization 
product of the acetylenic compounds rather than Mannich adduct, if 
the secondary amines are strained such as aziridine or azetidine, and 
this may attributed to steric factors that hinder the formation of a 
shift base between the amine and formaldehyde.  
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